Your browser doesn't support javascript.
loading
Neurocognitive trajectory and proteomic signature of inherited risk for Alzheimer's disease.
Paranjpe, Manish D; Chaffin, Mark; Zahid, Sohail; Ritchie, Scott; Rotter, Jerome I; Rich, Stephen S; Gerszten, Robert; Guo, Xiuqing; Heckbert, Susan; Tracy, Russ; Danesh, John; Lander, Eric S; Inouye, Michael; Kathiresan, Sekar; Butterworth, Adam S; Khera, Amit V.
Afiliação
  • Paranjpe MD; Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, United States of America.
  • Chaffin M; Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, United States of America.
  • Zahid S; Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, United States of America.
  • Ritchie S; Cambridge Baker Systems Genomics Initiative, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
  • Rotter JI; Cambridge Baker Systems Genomics Initiative, Baker Heart & Diabetes Institute, Melbourne, Victoria, Australia.
  • Rich SS; British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
  • Gerszten R; British Heart Foundation Centre of Research Excellence, University of Cambridge, Cambridge, United Kingdom.
  • Guo X; National Institute for Health Research Cambridge Biomedical Research Centre, University of Cambridge and Cambridge University Hospitals, Cambridge, United Kingdom.
  • Heckbert S; The Institute for Translational Genomics and Population Sciences, Department of Pediatrics, The Lundquist Institute for Biomedical Innovation at Harbor-University of California, Los Angeles Medical Center, Torrance, California, United States of America.
  • Tracy R; Center for Public Health Genomics, University of Virginia, Charlottesville, Virginia, United States of America.
  • Danesh J; Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, United States of America.
  • Lander ES; Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School.
  • Inouye M; The Institute for Translational Genomics and Population Sciences, Department of Pediatrics, The Lundquist Institute for Biomedical Innovation at Harbor-University of California, Los Angeles Medical Center, Torrance, California, United States of America.
  • Kathiresan S; Department of Epidemiology, University of Washington, Seattle, Washington, United States of America.
  • Butterworth AS; Department of Biochemistry, Larner College of Medicine, University of Vermont, Burlington, Vermont, United States of America.
  • Khera AV; British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
PLoS Genet ; 18(9): e1010294, 2022 09.
Article em En | MEDLINE | ID: mdl-36048760
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Alzheimer Tipo de estudo: Etiology_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Humans / Middle aged Idioma: En Revista: PLoS Genet Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Alzheimer Tipo de estudo: Etiology_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Humans / Middle aged Idioma: En Revista: PLoS Genet Ano de publicação: 2022 Tipo de documento: Article